Pavmed Inc (PAVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,734 | -19,633 | -56,126 | -36,447 | -22,779 |
| Depreciation Amortization | 1,031 | 216 | 226 | 60 | 28 |
| Accounts receivable | 200 | 111 | -200 | -200 | N/A |
| Accounts payable and accrued liabilities | 1,057 | 3,922 | 174 | 2,911 | 650 |
| Other Working Capital | -1,734 | 2,311 | -1,566 | 78 | -1,550 |
| Other Operating Activity | 13,359 | 810 | 16,901 | 9,784 | 7,855 |
| Operating Cash Flow | $-34,821 | $-12,263 | $-40,591 | $-23,814 | $-15,796 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -926 | -574 | -1,469 | -192 | -157 |
| Net Acquisitions | -2,200 | N/A | -2,247 | -147 | -47 |
| Investing Cash Flow | $-3,126 | $-574 | $-3,716 | $-339 | $-204 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -14,970 | -14,970 | -14,970 |
| Common Stock Issued | 1,208 | 645 | 126,256 | 60,520 | 58,236 |
| Common Stock Repurchased | -366 | -329 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -6,977 | -1,312 | -1,312 |
| Financing Cash Flow | $25,842 | $316 | $104,309 | $44,238 | $41,954 |
| Beginning Cash Position | 77,258 | 77,258 | 17,256 | 17,256 | 17,256 |
| End Cash Position | 65,153 | 64,737 | 77,258 | 37,341 | 43,210 |
| Net Cash Flow | $-12,105 | $-12,521 | $60,002 | $20,085 | $25,954 |
| Free Cash Flow | |||||
| Operating Cash Flow | -34,821 | -12,263 | -40,591 | -23,814 | -15,796 |
| Capital Expenditure | -926 | -574 | -1,469 | -192 | -157 |
| Free Cash Flow | -35,747 | -12,837 | -42,060 | -24,006 | -15,953 |